Catalogo dei prodotti della ricerca

MATRISCIANO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.482
EU - Europa 296
AS - Asia 214
SA - Sud America 17
AF - Africa 6
OC - Oceania 1
Totale 2.016
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.475
IT - Italia 93
CN - Cina 84
IN - India 68
SG - Singapore 58
SE - Svezia 47
FI - Finlandia 43
UA - Ucraina 40
DE - Germania 27
AR - Argentina 16
GB - Regno Unito 16
IE - Irlanda 13
BG - Bulgaria 8
CA - Canada 5
TG - Togo 5
GR - Grecia 3
MX - Messico 2
RO - Romania 2
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
FR - Francia 1
HR - Croazia 1
IL - Israele 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
SA - Arabia Saudita 1
VE - Venezuela 1
Totale 2.016
Salva come PNG Salva come JPEG
Città #
Fairfield 261
Chandler 176
Ashburn 119
Seattle 114
Woodbridge 98
Wilmington 79
Houston 75
Ann Arbor 71
Beijing 63
Cambridge 63
Rome 46
Princeton 36
Singapore 36
Plano 35
San Paolo di Civitate 23
San Diego 22
Bremen 21
Millbury 21
Lawrence 19
Boardman 18
Norwalk 17
Boston 16
Federal 15
Andover 14
Dublin 13
Jacksonville 12
Des Moines 9
Dearborn 8
Helsinki 8
Sofia 8
New York 7
Fremont 6
Lomé 5
Falls Church 4
Buffalo 3
Castellammare Di Stabia 3
Follonica 3
Hefei 3
Nanjing 3
Toronto 3
London 2
Mannheim 2
Mexico City 2
Milan 2
Nanchang 2
Naples 2
Quzhou 2
San Mateo 2
Acton 1
Assisi 1
Baku 1
Baotou 1
Brussels 1
Buenos Aires 1
Bühl 1
Canicattì 1
Chambly 1
Changsha 1
Charenton-le-Pont 1
Charleston 1
Chongqing 1
Colombo 1
Distrito Federal 1
Florence 1
Frankfurt am Main 1
Indiana 1
Kaunas 1
Kunming 1
Las Vegas 1
Montréal 1
Nanning 1
Phoenix 1
Redmond 1
Riyadh 1
Shaoxing 1
Shenyang 1
Southend 1
Springfield 1
Sydney 1
Tappahannock 1
Tel Aviv 1
Thessaloniki 1
Wenzhou 1
Zagreb 1
Totale 1.608
Salva come PNG Salva come JPEG
Nome #
Activation of group II metabotropic glutamate receptors promotes DNA demethylation in the mouse brain. 91
Enhanced mGlu5-receptor dependent long-term depression at the Schaffer collateral-CA1 synapse of congenitally learned helpless rats 88
Pharmacological Activation of Group-II Metabotropic Glutamate Receptors Corrects a Schizophrenia-Like Phenotype Induced by Prenatal Stress in Mice 84
Simultaneous analysis of diazepam and its metabolites in rat plasma and brain tissue by HPLC-UV and SPE 82
Nanomolar concentrations of anabolic-androgenic steroids amplify excitotoxic neuronal death in mixed mouse cortical cultures 75
Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740. 74
Comparative effects of levobupivacaine and racemic bupivacaine on excitotoxic neuronal death in culture and N-methyl-D-aspartate-induced seizures in mice 72
Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis 72
Endogenous activation of group II metabotropic glutamate receptors inhibits the hypothalamic-pituitary-adrenocortical axis. 70
GROUP-II METABOTROPIC GLUTAMATE RECEPTOR LIGANDS AS ADJUNCTIVE DRUGS IN THE TREATMENT OF DEPRESSION: A NEW STRATEGY TO SHORTEN THE LATENCY OF ANTIDEPRESSANT MEDICATION? 69
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. 69
Metabotropic glutamate 2/3 receptors and epigenetic modifications in psychotic disorders: a review 67
Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice 66
Exposure to predator odor and resulting anxiety enhances the expression of the α2δ subunit of voltage-sensitive calcium channels in the amygdala 66
L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors 65
The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders 64
null 64
Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus. 62
Endogenous activation of group-II metabotropic glutamate receptors inhibits the hypothalamic-pituitary-adrenocortical axis. 61
Repeated anabolic androgenic steroid treatment causes antidepressant-reversible alterations of the hypothalamic - pituitary - adrenal axis, BDNF levels and behavior 61
Enhanced expression of the neuronal K+/Cl- cotransporter, KCC2, in spontaneously depressed Flinders Sensitive Line rats 61
Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of beta-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands. 52
Induction of the Wnt Antagonist Dickkopf-1 Is Involved in Stress-Induced Hippocampal Damage 49
GROUP II METABOTROPIC GLUTAMATE RECEPTOR LIGANDS INDUCE NEUROGENESIS IN CEREBELLAR GRANULAR CELL CULTURES 48
GLI AGONISTI DEI RECETTORI METABOTROPICI DI GRUPPO II COME FARMACI IN AGGIUNTA PER LA TERAPIA DEL DISTURBO DEPRESSIVO: UNA NUOVA STRATEGIA PER RIDURRE LA LATENZA DEGLI ANTIDEPRESSIVI? 45
Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depressione: a new strategy to shorten the latency of antidepressant medication? 43
Metabotropic glutamate receptors and neuroadaptation to antidepressants: study on imipramine induced down-regulation of b–Adrenergic receptors in mice treated with mGluR2/3 receptor ligands 41
DEFECTIVE GROUP-II METABOTROPIC GLUTAMATE RECEPTORS IN THE HIPPOCAMPUS OF SPONTANEOUSLY DEPRESSED RATS 41
EFFECTS OF SERTRALINE, ESCITALOPRAM OR VENLAFAXINE TREATMENT ON SERUM BDNF LEVELS IN PATIENTS WITH ANXIETY-DEPRESSIVE DISORDERS 36
LOW CONCENTRATIONS OF MGLU2/3 METABOTROPIC GLUTAMATE RECEPTOR AGONISTS MIMIC THE ACTION OF FLUOXETINE IN PROMOTING PROLIFERATION OF CEREBELLAR GRANULE CELL NEUROPRECURSORS IN CULTURES 35
Metabotropic glutamate (mGlu) 2/3 receptors and depressive disorder: New pharmacological targets to shorten the clinical latency of antidepressant drugs and potential involvement the pathophysiology of depression 33
LIVELLI SIERICI DI BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) NEI DISTURBI D’ANSIA E DELL’UMORE: EFFETTI DEGLI ANTIDEPRESSIVI 32
Metabotropic glutamate receptors and neuroadaptation to antidepressants: study on imipramine induced down-regulation of b1 –Adrenergic receptor in mice treated with mGluR2/3 ligands 28
Low concentrations of mGlu2/3 metabotropic glutamate receptor agonists mimic the action of fluoxetine in promoting proliferation of cell neuroprecursors in cultures 27
Targeting mGlu receptors for optimization of antipsychotic activity and disease-modifying effect in schizophrenia 18
THE MGLU2/3 METABOTROPIC RECEPTOR AGONIST, LY379268, ENHANCES THE ANTIDEPRESSANT EFFECT OF CHLORIMIPRAMINE IN DEPRESSIVE-PRONE FLINDERS SENSITIVE LINE (FSL) RATS 16
SYNERGISM BETWEEN THE MGLU2/3 METABOTROPIC RECEPTOR AGONIST, LY379268, AND CHLORIMIPRAMINE ON ANTIDEPRESSANT EFFECT IN DEPRESSIVE-PRONE FLINDERS SENSITIVE LINE (FSL) RATS 15
Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia 12
Altered Expression and In Vivo Activity of mGlu5 Variant a Receptors in the Striatum of BTBR Mice: Novel Insights Into the Pathophysiology of Adult Idiopathic Forms of Autism Spectrum Disorders 3
Totale 2.057
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.117
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020543 73 28 3 28 57 52 70 69 54 49 45 15
2020/2021103 11 17 9 10 1 8 1 15 12 6 9 4
2021/2022379 2 21 44 2 41 5 1 43 37 33 70 80
2022/2023441 71 96 20 80 40 43 1 28 45 6 10 1
2023/2024160 8 24 2 15 8 18 6 10 2 24 22 21
2024/202520 20 0 0 0 0 0 0 0 0 0 0 0
Totale 2.057